Atlas Trials

Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects

Clinical trial NCT05718518 · COMPLETED

Trial details

NCT number
NCT05718518
Sponsor
Ascletis Pharmaceuticals Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HealthyCOVID-19
Start date
2023-01-13
Primary completion
2023-04-14
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.